Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Umang Munjal"'
Publikováno v:
British Journal of Nutrition. 102:663-671
Epidemiological evidence suggests that the intake of prebiotic dietary fibres, for example, inulin, protects against colorectal cancer. However, little is known about cellular responses to complex fermentation samples. Therefore, we prepared a fermen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b3efb3e04cf81102f4e36d1b6c79f2a
https://doi.org/10.1017/s0007114509274770
https://doi.org/10.1017/s0007114509274770
Autor:
Michael Glei, Claudia Miene, Anke Borowicki, Thomas Hofmann, Stefanie Klenow, Katrin Stein, Daniel Scharlau, Umang Munjal, Nina Habermann
Publikováno v:
Mutation Research/Reviews in Mutation Research. 682:39-53
Dietary fibres are indigestible food ingredients that reach the colon and are then fermented by colonic bacteria, resulting mainly in the formation of short-chain fatty acids (SCFA) such as acetate, propionate, and butyrate. Those SCFA, especially bu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a62599118344c769f5a3f782df784bf
https://doi.org/10.1016/j.mrrev.2009.04.001
https://doi.org/10.1016/j.mrrev.2009.04.001
Autor:
Jean Gabert, Sandrine Hayette, Martin C. Müller, Nancy Boeckx, Elisabeth Oppliger Leibundgut, Carsten Hirt, Gareth Gerrard, Kostas Stamatopoulos, Gisela Barbany-Bustinza, Hans Ehrencrona, Annika Dufour, Frank Stegelmann, Katerina Zoi, Renata Zadro, Enrico Gottardi, Georg Hess, Lihui Wang, Tali Tohami, Tadej Pajič, Joana Diamond, Philippe Schafhausen, Josep F. Nomdedeu, Michael V. Dubina, Nils von Neuhoff, Ugur Ozbek, Dolors Colomer, Thomas Schenk, Steffen Koschmieder, Martin Roskos, Rüdiger Hehlmann, Tomasz Sacha, Mindaugas Stoškus, Dag Andre Nymoen, Thomas Ernst, A. V. Misyurin, Peter J. M. Valk, Christian Thiede, Lars Galonska, Heike Pfeifer, Thomas Lion, Kadri Raudsepp, Helen E. White, Susanne Schnittger, Hakim El Housni, Gerlinde Mitterbauer-Hohendanner, Philipp Erben, Jean-Michel Cayuela, Vincent H. J. van der elden, Barbara Izzo, Jeroen Janssen, Lykke Grubach, Giovanni Martinelli, Hajnalka Andrikovics, Andreas Hochhaus, Rodica Talmaci, Claude Preudhomme, Thoralf Lange, Jiri Mayer, Peter Rohon, Veli Kairisto, Christiane Pott, Giuseppe Saglio, Umang Munjal, Jana Rulcova, Francois-Xavier Mahon, Nicholas C.P. Cross
Publikováno v:
Blood. 116:893-893
Abstract 893 Introduction: A European collaborative harmonization study involving 61 laboratories is being conducted under the auspices of the European Treatment and Outcome Study (EUTOS) for CML that aims to facilitate reporting of molecular BCR-ABL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f6e87543f07a548742d6a15e574b991
https://doi.org/10.1182/blood.v116.21.893.893
https://doi.org/10.1182/blood.v116.21.893.893
Autor:
Philipp Erben, Stefan W. Krause, Hans J. Kolb, Wolf-Karsten Hofmann, Dominik Heim, Martin C. Mueller, Hermann Heimpel, Mridul Agrawal, Armin Leitner, Jörg Hasford, Rüdiger Hehlmann, Hans Pralle, Benjamin Hanfstein, D. K. Hossfeld, Juliana Popa, Hannah Daikeler, Andreas Hochhaus, Umang Munjal, Gabriela M. Baerlocher, Daniel Nowak, Christoph Nerl, Susanne Saussele
Publikováno v:
Blood. 116:671-671
Abstract 671 Introduction: The goal of imatinib therapy in newly diagnosed CML patients is the rapid achievement of cytogenetic and molecular responses. However, suboptimal response or resistance occur in a significant proportion of patients. BCR-ABL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e985768d6bf39fbe7d49eb37c880293
https://doi.org/10.1182/blood.v116.21.671.671
https://doi.org/10.1182/blood.v116.21.671.671